[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-420101-105":59,"doc-detail-420101-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","lipid-pharmacology-volume-2-contents","Lipid Pharmacology - Volume 2 - Contents","","Lipid Pharmacology, Volume II (1976), presents an organized reference for research and clinical study of lipid biology and lipid-related therapeutics. The contents cover major topics including clinical evaluation of atherosclerosis, advances in essential fatty acids, and methods for assessing hypolipidemic drugs in human physiology. It also details dietary and drug regulation of cholesterol metabolism, including cholesterol and triglyceride handling, dietary interventions, plant sterols, bile acid sequestrants, and lipid-lowering agents, supported by references and structured chapter subsections.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lipid-pharmacology-volume-2-contents/420101/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lipid-pharmacology-volume-2-contents/420101.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-28",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What topics are included in this volume’s contents?","Question",{"text":113,"@type":114},"The contents include clinical evaluation of atherosclerosis, essential fatty acids and their recent developments, evaluation methods for hypolipidemic drugs in man, and dietary and drug regulation of cholesterol metabolism.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which chapter focuses on essential fatty acids?",{"text":118,"@type":114},"Chapter 2, titled “Essential Fatty Acids - Recent Developments,” covers requirements, tissue lipids, deficiency, transport, and relationships with vitamin E, LCAT, brain development, and disease states.",{"name":120,"@type":111,"acceptedAnswer":121},"How is the material structured for studying hypolipidemic drugs?",{"text":122,"@type":114},"Chapter 3 provides methods for evaluation in man, outlining cholesterol and triglyceride metabolism measures and describing mechanisms of action for lipid-lowering agents, followed by references.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},420101,1790663550,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","# A SERIES OF MONORAPHVOLUME 2-11\n\n:  \nThe Andersonian Library  \n“所L  \n49(97  \n129177  \nBooks are to be returned on or before  \nthe last date below  \n\n| 26 MAY 1992  \u003Cbr>10   | 一×3881   |  |\n| --- | --- | --- |\n\n\n| WN  \u003Cbr>Y  \u003Cbr>C  yn  \u003Cbr>L   |\n| --- |\n\n\n|  |\n|\n\nANDERSNIANLISRARY  \nLIPID PHARMACOLOGY  \nVolume ll  \n# MEDICINAL CHEMISTRYA Series of Monographs\n\nEDITED BY  \nGEORGE DESTEVENS  \nCIBA Pharmaceutical Company,A Division of ClBA CorporationSummit,New Jersey  \nVolume 1.GEORGE DESTEVENS.Diuretics:Chemistry and Pharmacology.1963Volume 2.RoDOLFO PAOLETTI(ED.).Lipid Pharmacology.Volume I.1964.RoDOLFO PAOLETTI AND CHARLES J.GLUECK(EDS.).Volume II.1976  \nVolume 3.E.J.ARIENS(ED.).Molecular Pharmacology:The Mode of Actionof Biologically Active Compounds.(In two volumes.)1964  \nVolume 4.MAXWELL GORDON(ED.).Psychopharmacological Agents.Volume  \nI.1964.Volume II.1967.Volume III.1974.Volume IV.1976Volume 5.GEORGE DESTEVENS(ED.).Analgetics.1965  \nVolume 6.RoLAND H.THORP AND LEONARD B.CoBBIN.Cardiac StimulantSubstances.1967  \nVolume 7.EMIL SCHLITTLER(ED.).Antihypertensive Agents.1967Volume 8.U.S.VON EULER AND RUNE ELIASSON.Prostaglandins.1967Volume 9.G.D.CAMPBELL(ED.).Oral Hypoglycaemic Agents:Pharma-cology and Therapeutics.1969  \nVolume 10.LEMONT B.KIER.Molecular Orbital Theory in Drug Research.1971  \nVolume 11.E.J.ARIENS(ED.).Drug Design.Volumes I and I.1971.Vol-ume III.1972.Volume IV.1973.Volumes V and VI.1975.VolumeVII.in preparation  \nVolume 12.PAUL E.THOMPSON AND LESLIE M.WERBEL.AntimalarialAgents:Chemistry and Pharmacology.1972  \nVolume 13.ROBERT A.SCHERRER AND MICHAEL W.WHITEHOUSE(Eds.).Antiinflammatory Agents:Chemistry and Pharmacology.(In two vol-umes.)1974In Preparation  \nLEMONT B.KIER AND LoWELLH.HALL.Molecular Connectivity in Chem-istry and Drug Research  \nLIPIDPHARMACOLOGY  \nVolume ll  \nEDITED BY  \nRODOLFO PAOLETTI  \nINSTITUTE OF PHARMACOLOGYUNIVERSITY OF MILANMILAN,ITALY  \nAND  \nCHARLES J.GLUECK  \nDEPARTMENT OF INTERNAL MEDICINE  \nUNIVERSITY OF CINCINNATI MEDICAL CENTERCINCINNATI,OHIO  \n1976  \nACADEMIC PRESS·New York·San Francisco·London  \nCoPYRIGHT ◎1976,BY ACADEMIC PRESS,INC.ALL RIGHTS RESERVED.  \nNO PART OF THIS PUBLICATION MAY BE REPRODUCED ORTRANSMITTED IN ANY FORM OR BY ANY MEANS,ELECTRONICOR MECHANICAL,INCLUDING PHOTOCOPY,RECORDING,OR ANYINFORMATION STORAGE AND RETRIEVAL SYSTEM,WITHOUTPERMISSION IN WRITING FROM THE PUBLISHER.  \nACADEMIC PRESS,INC.111 Fifth Avenue,New York,New York 10003  \nUnited Kingdom Edition published by  \nACADEMIC PRESS,INC.(LONDON)LTD.24/28 Oval Road.London NW1  \nLibrary of Congress Cataloging in Publication Data  \nPaoletti,Rodolfo,ed.Lipid pharmacology.  \n(Medicinal chemistry;a series of monographs,  \nv.2.  )  \nVol.2 edited by R.Paolettiand C.J.Glueck.Includes bibliographies and index.  \n1.   Lipid metabolism.    2.   Drug metabolism.  \nI.  Glueck,Charles J.II.  Title.III.  Series.QP751.P331964612'.39763-21396ISBN 0-12-544952-6  \nPRINTED IN THE UNITED STATES OF AMERICA  \nD  \nb15.139  \nCONTENTS  \nCONTRIBUTORS ……………  \n……………………………xi  \nPREFACE ……………………………  \n………………xiii  \nCONTENTS OF VOLUME I………  \nChapter 1  \nCLINICAL EvALUATION OF ATHEROSCLEROSIS  \n· G. Schettler and H.Mörl  \nI. General Introductory Remarks ………………………………………………  \nII. Aortic Atherosclerosis ………………………………………………………………4  \nII. Atherosclerosis of the Coronary Arteries(Coronary  \nHeart Disease)………………………………………………………………………………14  \nIV. Atherosclerosis of the Extremities(Occlusive Arterial  \nDiseases)………………………………………………………………………………………………29  \nV. Atherosclerosis of the Arterioles and Capillaries,  \nParticularly of the Fundus of the Eye ………………………………34  \nVI. Atherosclerosis of the Pulmonary Arteries …………………………35  \nVII. Diabetic Angiopathy ………………………………………………………………36  \nReferences ………………………………………………………………………………………………38  \nChapter 2  \nESSENTIAL FATTY AcIDs-RECENT DEVELOPMENTS  \n· Roslyn B.Alfin-Slater and Lilla Aftergood  \nI. Introduction………………………………………………  \n…………………………………43  \nII. The Requirement for Essential Fatty Acids ………………………44  \nIII. EFA and Tiss","cbCaieBMxmZNmbBD","https://ap.wps.com/l/cbCaieBMxmZNmbBD","pdf",21371771,352,"English","# Contents\n## Contributors\n## Preface\n## Contents of Volume I\n## Chapter 1: Clinical Evaluation of Atherosclerosis\n## Chapter 2: Essential Fatty Acids - Recent Developments\n## Chapter 3: Methods for Evaluation of Hypolipidemic Drugs in Man: Mechanisms of Their Action\n## Chapter 4: Dietary and Drug Regulation of Cholesterol Metabolism in Man","[{\"question\":\"What topics are included in this volume’s contents?\",\"answer\":\"The contents include clinical evaluation of atherosclerosis, essential fatty acids and their recent developments, evaluation methods for hypolipidemic drugs in man, and dietary and drug regulation of cholesterol metabolism.\"},{\"question\":\"Which chapter focuses on essential fatty acids?\",\"answer\":\"Chapter 2, titled “Essential Fatty Acids - Recent Developments,” covers requirements, tissue lipids, deficiency, transport, and relationships with vitamin E, LCAT, brain development, and disease states.\"},{\"question\":\"How is the material structured for studying hypolipidemic drugs?\",\"answer\":\"Chapter 3 provides methods for evaluation in man, outlining cholesterol and triglyceride metabolism measures and describing mechanisms of action for lipid-lowering agents, followed by references.\"}]","Lipid Pharmacology - Volume 2 - Contents | PDF",1790619513,887]